Advertisement

Topics

FDA gives nod to Janssen for new indication for Xarelto

14:01 EDT 12 Oct 2018 | Drug Store News

pharmacy/fda-gives-nod-to-janssen-for-new-indication-for-xarelto/">

The FDA has approved Janssen's blood thinner Xarelto to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease.

Read More

Original Article: FDA gives nod to Janssen for new indication for Xarelto

NEXT ARTICLE

More From BioPortfolio on "FDA gives nod to Janssen for new indication for Xarelto"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...